Pharma
Johnson & Johnson to buy Proteologix for $850m
J&J will acquire drugs in development for eczema and asthma.
Clinical Development
Analysis of clinical development, exploring the key drivers, future outlook, and impact of this critical sector on the broader healthcare industry.
Pharma
How AstraZeneca is making up for declining Covid-19 sales
The British drugmaker saw a steep decline in sales of its Covid-19 vaccine and antibody drugs in 2023.
Pharma
AstraZeneca has big R&D goals to mitigate future declines in Covid-related sales
CEO Pascal Soriot expects a “very substantial decline” in 2023 Covid-related sales.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
